Pharma channel feed

FDA sends warn­ing let­ter to com­mu­ni­ty hos­pi­tal re­view board over re­search con­cerns

3 years ago
FDA+

Mer­ck halts prostate can­cer study while re­port­ing pos­i­tive read­out in bil­iary tract can­cer

3 years ago
R&D

Lon­za posts full 2022 re­sults as it looks to buy back $2B+ in shares

3 years ago
Manufacturing

No­var­tis re-en­lists spokescelebri­ty Ken Jeong for Xi­idra movie trail­er spoof cam­paign

3 years ago
Marketing

EMA changes or­phan des­ig­na­tion pol­i­cy for cer­tain eye drugs to ex­pand ac­cess

3 years ago
FDA+

Sanofi takes to Tik­Tok and In­sta­gram to tar­get mil­len­ni­als and old­er Gen Z par­ents for RSV ed­u­ca­tion

3 years ago
Marketing

J&J qui­et­ly punts a pair of ear­ly-stage bis­pecifics for sol­id tu­mors

3 years ago
R&D

Con­struc­tion on Mer­ck­'s Lon­don re­search hub set to be­gin in April 2023

3 years ago
R&D
Discovery

J&J re­it­er­ates 2025 sales goal de­spite loom­ing Ste­lara ex­clu­siv­i­ty loss, glob­al eco­nom­ic chal­lenges

3 years ago

Pfiz­er taps Pink, Michael Phelps and oth­er celebri­ties in lat­est Covid cam­paign

3 years ago
Marketing

Can­cer cell-based ther­a­pies com­ing in­to 'im­por­tan­t' year for R&D, say SVB an­a­lysts

3 years ago
Cell/Gene Tx

San­doz signs deal for an­ti­fun­gal from Astel­las in buff-up of an­ti-in­fec­tives port­fo­lio

3 years ago
Deals

No­var­tis pe­ti­tions Supreme Court in ef­fort to 'vig­or­ous­ly de­fend' Gilenya patent

3 years ago
FDA+
Law

Q&A: As­traZeneca res­pi­ra­to­ry/im­munol­o­gy mar­ket­ing chief talks ad strate­gies with in­flu­encers, per­son­al­iza­tion and more

3 years ago
Marketing

Mar­ket­ingRx: Bio­gen's new CEO talks DTC for de­pres­sion drug can­di­date; Ab­b­Vie de­buts Skyrizi TV ad for Crohn’s

3 years ago
Marketing

WHO push­es for ac­tion by man­u­fac­tur­ers and gov­ern­ments af­ter warn­ings over con­t­a­m­i­nat­ed cough syrups

3 years ago
Manufacturing

Ad­vo­ca­cy group ac­cus­es No­vo Nordisk of vi­o­lat­ing FDA's 'fair bal­ance' ad­ver­tis­ing rules

3 years ago
FDA+
Marketing

FDA lays the fin­ish­ing touch­es on its plan to pull Mak­e­na

3 years ago
FDA+

Ab­b­Vie cuts rib­bon on can­cer pa­tient and fam­i­ly re­treat space at St. Jude, fund­ed by $50M pledge

3 years ago
Marketing

Af­ter Lil­ly com­plaint, No­var­tis pulls claim in DTC can­cer drug ad

3 years ago
Marketing

Ther­a­cos­Bio aims to chal­lenge Big Phar­ma block­busters with new­ly-ap­proved SGLT2 for di­a­betes

3 years ago
R&D

Sanofi, Ab­b­Vie, MSD pledge with Pub­li­cis and con­sumer brand co­hort to end can­cer stig­ma at work

3 years ago
Marketing

UK's NICE stamps ap­proval on Al­ny­lam, PTC rare dis­ease drugs

3 years ago

Sanofi promis­es mon­ey back for dis­con­tin­ued blood dis­or­der treat­ment – in some cas­es

3 years ago
First page Previous page 148149150151152153154 Next page Last page
A service from the Financial Times